Events & conferences in the Life Sciences industry

Online


With the highest attending rate of academics, TTOs and research institutions, BioFIT is the place where academia-industry collaborations get started. BioFIT has taken on a whole new dimension becoming the meeting point in Europe for tech transfer and for sourcing early-stage innovations stemming from public research institutions, academic spin-offs and emerging biotech companies. Together with big pharma, biotech and diagnostic companies, BioFIT operates as a platform to build partnerships for all public and private actors. BioFIT is also the European marketplace for pre-seed, seed and Series A investment in Life Sciences.

Online


With 700 international participants from 25+ countries, MedFIT is your opportunity to connect with international key innovators in the MedTech, diagnostic and digital health sectors. As a leading European partnering event, MedFIT provides the ideal environment to help industry players to source early-stage assets, to facilitate the emergence of collaborative projects between big players, public research institutions, start-ups and SMEs, to increase licensing opportunities, to obtain funding and to facilitate market access.

San Francisco United States

The annual J.P. Morgan Healthcare Conference is the largest and most informative healthcare investment symposium in the industry, bringing together industry leaders, emerging fast-growth companies, innovative technology creators, and members of the investment community.

San Francisco, CA & Virtually


Biotech Showcase™ is the annual conference for Innovators. If you attend as a general attendee, Biotech Showcase and its family of events will give you the opportunity to re-connect with your peers, in-person or virtually, via seamless one-to-one networking. If you are an Investor, this event gives you the opportunity to find thousands of investment opportunities with participating companies ranging from early, mid to later stage, from Startup, over Biotech and large Pharma.

Zurich Switzerland

Swiss Nordic Bio in Zurich is a high-level partnering and investor event where Swiss and Nordic biotech startups, pharmaceutical companies and investors meet. Swiss Nordic Bio carries 15 years of tradition, previously Swiss Scandinavian Bio-Business Seminar, and is organised by the Nordic countries in cooperation with Swiss partners. The conference has a broad focus within biotech and pharma (drug development, drug delivery, bio materials, medical device, diagnostics, contract manufacturing, CRO, etc.) and gathers small, early stage companies as well as global, commercial corporations. The conference is open for biotech and pharma companies as well as investors within the life science industry.

Online or New York, USA


For more than 20 years, the BIO CEO & Investor Conference has fueled the biotech industry networking with premier investor and banking communities, focused on established and emerging publicly traded and select private biotech companies. Join us in 2022 - either in person or online - for one of the largest investor conferences focused on established and emerging publicly traded and select private biotech companies, where institutional investors, industry analysts, and senior biotechnology executives have the opportunity to shape the future investment landscape of the biotechnology industry

Basel Switzerland

BIO-Europe Spring® 2022 will bring together the life science community for global dealmaking in-person and digitally. The event will feature one-to-one meetings, company presentations, informal networking, and pre-event courses. The key theme of the BIO-Europe Spring 2022 program, led by Novartis and Roche, will be Innovation. In addition, the rest of the program will focus on Business Development, Therapeutic Areas, and the Biotech Ecosystem.

Online

BIO-Europe Spring® 2022 will bring together the life science community for global dealmaking in-person and digitally. The event will feature one-to-one meetings, company presentations, informal networking, and pre-event courses. The key theme of the BIO-Europe Spring 2022 program, led by Novartis and Roche, will be Innovation. In addition, the rest of the program will focus on Business Development, Therapeutic Areas, and the Biotech Ecosystem.